See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Research Videos on Diabetes Health TV

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

FDA

Page 2
Type 1 Drug Wins Orphan Status
Jan 16, 2014 | 
DV-100, a drug designed to halt the body's autoimmune attack on pancreatic beta cells that leads to type 1 disease, has won orphan drug status from the U.S. Food and Drug Administration.
FDA Opens Way for Diabetic Macular Edema Device
Jan 1, 2014 | 
The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a new treatment for diabetic macular edema to reach the U.S. market.
DHTV
Popular
Top Rated

Related Research Videos on Diabetes Health TV

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Continuous Glucose Monitoring with DEXCOM's

Deb Ruppert

Continuous Glucose Monitoring with DEXCOM's "The Seven"

FDA Clears Novo's Kid-Friendly Insulin Pen
Aug 22, 2013 | 
The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on the market to combine half-unit dosing with a memory function to help patients manage their diabetes.
FDA Tells 15 Companies to Stop Illegal Diabetes Treatment Sales
Jul 27, 2013 | 
The U.S. Food and Drug Administration has announced that it has issued letters warning 15 U.S. and foreign companies to cease sales of products that the agency has determined are being illegally marketed.
FDA Approves Invokana, a New Type 2 Drug
Jun 27, 2013 | 
A new, first-in-its-class drug for type 2 diabetes has just been approved by the Food and Drug Administration. Invokana works by blocking re-absorption of glucose by the kidneys and stimulating urination, which removes glucose from the bloodstream.
FDA Panelists Vote to Ease Up on Avandia
Jun 9, 2013 | 
A significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the current restrictive label and distribution regulations affecting the type 2 drug Avandia.
Ready for a Diabetes Drug Tune-Up?
Jun 1, 2013 | 
People with diabetes know the score. We've all seen "revolutionary" drugs and treatments introduced with fanfare, and we know that that much of the time they're evolutionary at best. But something has changed in the world of diabetes care.
Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.